BACKGROUND: Non-invasive methods are desirable for longitudinal studies examining drug efficacy and disease resolution defined as decreases in epidermal thickness in mouse models of psoriasiform skin disease. This would eliminate the need for either sacrificing animals or collecting serial skin biopsies to evaluate changes in disease progression during an individual study. The quantitation of epidermal thickness using optical coherence tomography (OCT) provides an alternative to traditional histology techniques. METHODS: Using the KC-Tie2 doxycycline-repressible psoriasiform skin disease mouse model, OCT imaging was completed on diseased back skin of adult KC-Tie2 (n = 3-4) and control (n = 3-4) mice, followed immediately by the surgical excision of the same region for histologic analyses. Animals were then treated with doxycycline to suppress transgene expression and to reverse the skin disease and additional OCT images and tissues were collected 2 and 4 weeks following. Epidermal thickness was measured using OCT and histology. RESULTS: Optical coherence tomography and histology both demonstrated that KC-Tie2 mice had significantly thicker epidermis (~4-fold; P < 0.0001) than control animals. By 2 weeks following gene repression, decreases in epidermal thickness were observed using both OCT and histology, and were sustained through 4 weeks. Correlation analyses between histology and OCT values at all time points and in all animals revealed high significance (R(2) = 0.78); with correlation being highest in KC-Tie2 mice (R(2) = 0.92) compared to control animals (R(2) = 0.16). CONCLUSION: Non-invasive OCT imaging provided similar values as those collected using standard histologic measures in thick skin of KC-Tie2 mice but became less reliable in thinner control mouse skin, possibly reflecting limitations in resolution of OCT. Future advances in resolution of OCT may improve and allow greater accuracy of epidermal thickness measurements.
BACKGROUND: Non-invasive methods are desirable for longitudinal studies examining drug efficacy and disease resolution defined as decreases in epidermal thickness in mouse models of psoriasiform skin disease. This would eliminate the need for either sacrificing animals or collecting serial skin biopsies to evaluate changes in disease progression during an individual study. The quantitation of epidermal thickness using optical coherence tomography (OCT) provides an alternative to traditional histology techniques. METHODS: Using the KC-Tie2doxycycline-repressible psoriasiform skin diseasemouse model, OCT imaging was completed on diseased back skin of adult KC-Tie2 (n = 3-4) and control (n = 3-4) mice, followed immediately by the surgical excision of the same region for histologic analyses. Animals were then treated with doxycycline to suppress transgene expression and to reverse the skin disease and additional OCT images and tissues were collected 2 and 4 weeks following. Epidermal thickness was measured using OCT and histology. RESULTS: Optical coherence tomography and histology both demonstrated that KC-Tie2mice had significantly thicker epidermis (~4-fold; P < 0.0001) than control animals. By 2 weeks following gene repression, decreases in epidermal thickness were observed using both OCT and histology, and were sustained through 4 weeks. Correlation analyses between histology and OCT values at all time points and in all animals revealed high significance (R(2) = 0.78); with correlation being highest in KC-Tie2mice (R(2) = 0.92) compared to control animals (R(2) = 0.16). CONCLUSION: Non-invasive OCT imaging provided similar values as those collected using standard histologic measures in thick skin of KC-Tie2mice but became less reliable in thinner control mouse skin, possibly reflecting limitations in resolution of OCT. Future advances in resolution of OCT may improve and allow greater accuracy of epidermal thickness measurements.
Authors: Thilo Gambichler; Georg Moussa; Michael Sand; Daniel Sand; Peter Altmeyer; Klaus Hoffmann Journal: J Dermatol Sci Date: 2005-08-31 Impact factor: 4.563
Authors: Thilo Gambichler; Stefanie Boms; Markus Stücker; Alexander Kreuter; Michael Sand; Georg Moussa; Peter Altmeyer; Klaus Hoffmann Journal: J Biomed Opt Date: 2005 Jul-Aug Impact factor: 3.170
Authors: T Gambichler; G Moussa; P Regeniter; C Kasseck; M R Hofmann; F G Bechara; M Sand; P Altmeyer; K Hoffmann Journal: Phys Med Biol Date: 2007-01-31 Impact factor: 3.609
Authors: Jitendrakumar K Patel; Sailesh Konda; Oliver A Perez; Sadegh Amini; George Elgart; Brian Berman Journal: Eur J Dermatol Date: 2008-10-27 Impact factor: 3.328
Authors: Johann E Gudjonsson; Andrew Johnston; Melissa Dyson; Helgi Valdimarsson; James T Elder Journal: J Invest Dermatol Date: 2007-04-12 Impact factor: 8.551
Authors: Linh Ha-Wissel; Handan Yasak; Robert Huber; Detlef Zillikens; Ralf J Ludwig; Diamant Thaçi; Jennifer E Hundt Journal: Front Med (Lausanne) Date: 2022-09-27
Authors: Yunmei Wang; Huiyun Gao; Candace M Loyd; Wen Fu; Doina Diaconu; Shijian Liu; Kevin D Cooper; Thomas S McCormick; Daniel I Simon; Nicole L Ward Journal: J Invest Dermatol Date: 2012-05-10 Impact factor: 8.551